| 000 | 01515 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512211753.0 | ||
| 264 | 0 | _c19840608 | |
| 008 | 198406s 0 0 eng d | ||
| 022 | _a0003-990X | ||
| 024 | 7 |
_a10.1001/archpsyc.1984.01790160106014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevy, M I | |
| 245 | 0 | 0 |
_aApomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. _h[electronic resource] |
| 260 |
_bArchives of general psychiatry _cMay 1984 |
||
| 300 |
_a520-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aApomorphine _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
| 650 | 0 | 4 |
_aGrowth Hormone _xblood |
| 650 | 0 | 4 |
_aHomovanillic Acid _xcerebrospinal fluid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aProlactin _xblood |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 700 | 1 | _aDavis, B M | |
| 700 | 1 | _aMohs, R C | |
| 700 | 1 | _aKendler, K S | |
| 700 | 1 | _aMathé, A A | |
| 700 | 1 | _aTrigos, G | |
| 700 | 1 | _aHorvath, T B | |
| 700 | 1 | _aDavis, K L | |
| 773 | 0 |
_tArchives of general psychiatry _gvol. 41 _gno. 5 _gp. 520-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/archpsyc.1984.01790160106014 _zAvailable from publisher's website |
| 999 |
_c6372654 _d6372654 |
||